Supply Chain

Pfizer will end research into treatments for Alzheimer's and Parkinson's disease, resulting in the elimination of 300 positions at the company's Massachusetts facilities in Andover and Cambridge, and its Connecticut facility in Groton, reports The Wall Street Journal.

U.S. biopharmaceutical firm Celgene will acquire Impact Biomedicines, a San Diego-based startup focusing on developing treatments for complex cancers, for up to $7 billion, according to Reuters.

Medical device industry group AdvaMed on Friday launched a television ad campaign, urging Congress to kill the ACA's device tax, which took effect Jan. 1 after a two-year suspension, according to The Wall Street Journal.

Amgen on Friday earned expanded FDA approval for its drug Xgeva, reports Reuters.

The FDA expects IV fluid shortages to improve early this year after a leading manufacturer of IV saline bags — Baxter International — announced all of its facilities in Puerto Rico have returned to the commercial power grid.

MedStar Health, a 10-hospital system in Columbia, Md., stepped into the world of hospital fashion through a recent partnership with "healthwear" company Care+Wear to pilot a kimono-inspired hospital gown for patients to wear during their stay, The New York Times…

Here are seven articles Becker's Hospital Review published in the last week, highlighting Allergan's plan to cut 1,000 jobs and San Diego-based Dignity Health's efforts to reduce plastic straw use across the system's 39 hospitals, among other topics.

Scottsdale, Ariz.-based Primus Pharmaceuticals took its osteoarthritis treatment Limbrel off the market at the FDA's request, according to azcentral.

FDA Commissioner Scott Gottlieb, MD, on Wednesday outlined new steps the agency will take to spur more generic drug competition.

PharMEDium is recalling 55 lots of various drug products due to a lack of sterility assurance.